MYOM2 and cancer: The M-protein is produced more commonly by a malignant clone of plasma cells but may also be produced by clonal lymphoplasmacytic cells (as seen in Waldenström’s macroglobulinaemia).3 According to the 2019 Cancer Association of South Africa Cancer Registry statistics, MM accounted for 0.5% of all histologically diagnosed cancers.